Healthcare and Pre-Existing Conditions: Here's What You Need to Know
What is a pre-existing condition, and how is Trumpcare going to affect coverage rules for pre-existing medical conditions? Find out here.
1 Underdog Stock I'm Watching
Here are three former high-flyers that might be good buys -- if they can pull off turnarounds.
Costco Finally Sees Stronger Sales Growth
Rising comps and anticipated increases in membership fees bode well for the warehouse retailer.
These 3 Hated Dividend Stocks Are Buys
Wall Street isn't a fan of Helmerich & Payne, ONEOK, or CF Industries for some reason, but here's why they look like interesting investments today.
Tech is changing the nature of service at restaurants across the country.
Two cable industry giants join forces, but it remains to be seen if they have what it takes to break into wireless.
Qorvo is promising a turnaround, but investors need to be wary of a potential market-share loss.
Launches will continue for the next 12 months, but it's what could happen after that that makes the company exciting to watch.
Microsoft, Intel, IBM, NVIDIA, and Qualcomm are all putting serious resources into capturing a share of the burgeoning VR market -- and paying their investors while they do so.
A comparison of both companies' efforts in the fast-growing e-sports market.
June will be a pivotal month for shareholders of Portola Pharmaceuticals and Neos Therapeutics
Amazon clearly tops the list, but investors shouldn't overlook Shopify and Wayfair.
Paycom's future looks as bright as ever after recent comments from the company's CEO.
Apple appears to be developing a non-invasive glucose monitoring prototype that works with its Watch.
If you have a credit card, or plan to get one, you need to read this.
Will you be one of them?
Microsoft is set to release the most powerful video game console ever, but it might not be enough to change the course of the console race.
The investment in fast-casual Mexican food paid off for the burger chain, but it might be time to split up.
Since 2015, General Motors has pulled out of countries and regions representing more than a third of the world's population. Some pundits think this is a shortsighted strategy.
The real surprise is what this bill wouldn't legalize, if approved.
There are lot of companies focusing on cancer drugs that pay dividends. AbbVie, AstraZeneca, and Pfizer stand at the top of the list.
Looking for a few stocks that will supplement your monthly income? Here are three for you to consider.
If your home's value has not bounced back from the 2008 recession, it might just need a little boost.